20 employees
Cape Bio Pharms is a bio-research company that offers the production of recombinant proteins in Nicotiana benthamiana plants.
2018
$62M
from 2 investors over 2 rounds
Cape Bio Pharms (Pty) Ltd raised $62M on December 18, 2020
Investors: European Investment Bank and FIND, the global alliance for diagnostics